CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION RESTATED DEVELOPMENT AND COMMERCIALIZATION COLLABORATION AGREEMENT between OTSUKA PHARMACEUTICAL CO., LTD. and BRISTOL-MYERS...Development and Commercialization Collaboration Agreement • August 17th, 2009 • Bristol Myers Squibb Co • Pharmaceutical preparations • Delaware
This Restated Development and Commercialization Collaboration Agreement (this “Agreement”) is made and entered into as of October 23, 2001 (the “Restated Agreement Date”), by and between OTSUKA PHARMACEUTICAL CO., LTD. (“Otsuka”), a corporation organized and existing under the laws of Japan, having a principal place of business at 2-9, Kanda Tsukasa-cho, Chiyoda-ku, Tokyo, Japan, and BRISTOL-MYERS SQUIBB COMPANY (“BMS”), a corporation organized and existing under the laws of Delaware, having a principal place of business at Route 206 and Province Line Road, Princeton, New Jersey 08540, USA. This Agreement amends and restates that certain Development and Commercialization Collaboration Agreement between Otsuka and BMS dated September 20, 1999. The Effective Date of the Agreement, as amended and restated here, remains September 20, 1999.
DEVELOPMENT AND COMMERCIALIZATION COLLABORATION AGREEMENTDevelopment and Commercialization Collaboration Agreement • March 31st, 2008 • Cell Genesys Inc • Pharmaceutical preparations • New York
